SODIUM C12-13 PARETH-8 CARBOXYLATE
UNII P45HYN3407

Substance Identification & Data

This profile provides standardized clinical and technical data for Sodium C12-13 Pareth-8 Carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P45HYN3407.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
P45HYN3407
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SODIUM C12-13 PARETH-8 CARBOXYLATE
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
mixture
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sodium C12-13 Pareth-8 Carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SODIUM C12-13 ALKETH-8 CARBOXYLATE
SODIUM C12-13 PARETH-8 CARBOXYLATE

Common Names & Synonyms

POLYETHYLENE GLYCOL (8) C12-13 ALKYL ETHER CARBOXYLIC ACID, SODIUM SALT
POLYOXYETHYLENE (8) C12-13 ALKYL ETHER CARBOXYLIC ACID, SODIUM SALT

Brand / Trade Names

NEODOX 23-7, SODIUM SALT
PUREACT WNT-GEL